ALEMBIC PHARMACEUTICALS
|
The Current P/E Ratio of ALEMBIC PHARMACEUTICALS is 30.66.
Share Price | ₹937.1 | Aug 29,2025 |
Market Cap | ₹18,423.4 Cr | |
Earnings-TTM | ₹601.0 Cr | TTM-Consolidated Results |
Price/Earnings | 30.66x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of ALEMBIC PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹18,423.4 Cr] as on Aug 29,2025
(/) Earnings [ ₹601.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 30.66x ]
Thus, for ALEMBIC PHARMACEUTICALS , the investors are currently willing to pay 30.66 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ALEMBIC PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ALEMBIC PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of ALEMBIC PHARMACEUTICALS
PE Ratio Performance Analysis for ALEMBIC PHARMACEUTICALS
- ALEMBIC PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 27.14x.
- ALEMBIC PHARMACEUTICALS 's operated at median p/e ratio of 28.5x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ALEMBIC PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 31.35x.
- ALEMBIC PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 16.55x.
How does ALEMBIC PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
ALEMBIC PHARMACEUTICALS | 600.99 | 30.66 | 18,423.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 36.73 | 382,466.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 70.43 | 162,423.0 |
CIPLA LTD | 5,406.81 | 23.75 | 128,405.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 60.16 | 120,448.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 18.41 | 105,408.0 |
MANKIND PHARMA LTD | 1,905.51 | 53.53 | 102,011.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 21.28 | 98,696.5 |
LUPIN LTD | 3,722.18 | 23.23 | 86,468.2 |
AUROBINDO PHARMA LTD | 3,417.93 | 17.46 | 59,689.0 |
ABBOTT INDIA LTD | 1,452.29 | 46.09 | 66,930.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ALEMBIC PHARMACEUTICALS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.46x |
Max industry PE | 70.43x |
Median industry PE | 30.66x |
Average industry PE | 36.52x |
You may also like the below Video Courses